← Leaderboards
Lynne V Abruzzo
University Of Tx Md Anderson Can Ctr
$2,251,267
Attributed
$3,698,338
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $677.5K · FY2006–18$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$3,698,338 · 2
By mechanism
R01$3,698,338 · 2
Top collaborators
- George A. Calin5 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Leland Hu$3,569,147
- George A. Calin$5,774,539
- Jian Wang$160,000
- Cassian Yee$17,221,393
- Ashby J. Morrison$14,654,289
Others in their field
Top investigators on “Sampling”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$522,319,685
- David R. Weir · University Of Michigan At Ann Arbor$421,002,438
- David Heimbrook · Leidos Biomedical Research, Inc.$410,224,927
- Eric S Lander · Whitehead Institute For Biomedical Res$395,613,296
- Richard A Gibbs · Baylor College Of Medicine$356,778,395
Research focus
SamplingBiological MarkersIndolentMolecular ProfilingChronic Lymphocytic LeukemiaGenesLeukemiaCellsGene ExpressionStagingGuidelinesAftercareGenome-WideBiologicalHematopoietic NeoplasmsFollow-UpB-LymphocytesAdultBiologic CharacteristicDeep SequencingCodeDiagnosisDisease ProgressionAnemia
Grant awards (8)
Protein-coding and non-coding RNA biomarkers for early detection of CLL$534,489
R01 · FY2018 · CA
Protein-coding and non-coding RNA biomarkers for early detection of CLL$534,545
R01 · FY2017 · CA
Protein-coding and non-coding RNA biomarkers for early detection of CLL$574,442
R01 · FY2016 · CA
Protein-coding and non-coding RNA biomarkers for early detection of CLL$677,471
R01 · FY2015 · CA
Protein-coding and non-coding RNA biomarkers for early detection of CLL$573,195
R01 · FY2014 · CA
Validation of RNA and DNA Biomarkers of Prognosis in Chronic Lymphocytic Leukemia$265,423
R01 · FY2008 · CA · contact PI
Validation of RNA and DNA Biomarkers of Prognosis in Chronic Lymphocytic Leukemia$265,423
R01 · FY2007 · CA · contact PI
Validation of RNA and DNA Biomarkers of Prognosis in Chronic Lymphocytic Leukemia$273,350
R01 · FY2006 · CA · contact PI